Study of URC102 to Assess the Safety and Efficacy in Gout Patients

Status:
Completed

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

The purpose of this study is to assess safety, Pharmacokinetics/Pharmacodynamics and Urate Lowering Effect of URC102 in gout patients.

Phase 2

JW Pharmaceutical